These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 28157558

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interleukin 17A and interleukin 17F polymorphisms are associated with oral squamous cell carcinoma susceptibility in a Chinese population.
    Li N, Zhang C, Chen Z, Bai L, Nie M, Zhou B, Xu H.
    J Oral Maxillofac Surg; 2015 Feb; 73(2):267-73. PubMed ID: 25579009
    [Abstract] [Full Text] [Related]

  • 23. Genetic variation in interleukin-10 gene and risk of oral cancer.
    Yao JG, Gao LB, Liu YG, Li J, Pang GF.
    Clin Chim Acta; 2008 Feb; 388(1-2):84-8. PubMed ID: 17980158
    [Abstract] [Full Text] [Related]

  • 24. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.
    Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S319-27. PubMed ID: 21512861
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [Abstract] [Full Text] [Related]

  • 27. Cyclooxygenase-2-765G>C functional promoter polymorphism and its association with oral squamous cell carcinoma.
    Lakshmi A, Muralidhar S, Kalyan Kumar C, Pavan Kumar A, Kalyana Chakravarthy P, Anjaneyulu V, Kaiser J.
    J Investig Clin Dent; 2012 Aug; 3(3):182-8. PubMed ID: 22887904
    [Abstract] [Full Text] [Related]

  • 28. A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas.
    Yang CM, Chen HC, Hou YY, Lee MC, Liou HH, Huang SJ, Yen LM, Eng DM, Hsieh YD, Ger LP.
    Arch Oral Biol; 2014 Jan; 59(1):35-46. PubMed ID: 24169152
    [Abstract] [Full Text] [Related]

  • 29. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
    Kietthubthew S, Sriplung H, Au WW, Ishida T.
    Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
    [Abstract] [Full Text] [Related]

  • 30. IL-10 Promoter -592 Polymorphism may Influence Susceptibility to HIV Infection in South Indian Population.
    Harishankar M, Ravikrishnan H, Ravishankar A, Hanna LE, Swaminathan S, Selvaraj P, Bethunaickan R.
    Curr HIV Res; 2018 Jan; 16(1):58-63. PubMed ID: 29468971
    [Abstract] [Full Text] [Related]

  • 31. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
    Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A.
    Acta Oncol; 2009 Jan; 48(7):971-6. PubMed ID: 19642044
    [Abstract] [Full Text] [Related]

  • 32. Estimation of vascular endothelial growth factor gene -460 C/T polymorphism as a biomarker in oral squamous cell carcinoma patients from the Indian subcontinent.
    Borase AP, Ganvir SM, Hazarey VK, Gosavi SR, Mohatta AA, Singh J.
    J Investig Clin Dent; 2015 Nov; 6(4):267-72. PubMed ID: 25051952
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
    Gao C, Wang J, Li C, Zhang W, Liu G.
    PLoS One; 2016 Nov; 11(9):e0160801. PubMed ID: 27622501
    [Abstract] [Full Text] [Related]

  • 35. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY.
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [Abstract] [Full Text] [Related]

  • 36. TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese.
    Hsu HJ, Yang YH, Shieh TY, Chen CH, Kao YH, Yang CF, Ko EC.
    Kaohsiung J Med Sci; 2015 Mar; 31(3):123-9. PubMed ID: 25744234
    [Abstract] [Full Text] [Related]

  • 37. The COX2 genetic variants in oral squamous cell carcinoma in Turkish population.
    Cacina C, Kaşarci G, Bektaş K, Unur M, Cakmakoglu B.
    Cell Mol Biol (Noisy-le-grand); 2018 Nov 30; 64(14):96-100. PubMed ID: 30511628
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U, Tug E, Namli M.
    World J Biol Psychiatry; 2009 Nov 30; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [Abstract] [Full Text] [Related]

  • 40. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
    Lin YC, Huang HI, Wang LH, Tsai CC, Lung O, Dai CY, Yu ML, Ho CK, Chen CH.
    Oral Oncol; 2008 Aug 30; 44(8):798-804. PubMed ID: 18234542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.